Our Research


At Houston Methodist, fostering innovations with the potential for clinical application is at the very heart of what we do. Our interdisciplinary teams of clinicians and researchers are committed to streamlining the process of translating discoveries into treatments and cures for our patients. 

Learn more about how we are delivering on our commitment to leading medicine from the earliest phase of discovery in a lab to the testing new drugs or therapies in clinical trials.

$21 Million Gift Boosts Translational Research

A $21 million gift from the Jerold B. Katz Foundation aims to help researchers shorten the time between a scientific discovery and its successful use in humans. Learn more.


Houston Methodist received $9 million from the National Cancer Institute to establish a center focused on the physics of cancer immunotherapy. Mauro Ferrari, PhD, president and CEO of the Houston Methodist Research Institute, is leading this effort. Learn more.

Breast Cancer Discovery Advances to Clinical Trial

Houston Methodist researchers led by Jenny Chang, MD, have advanced a potential treatment for the most aggressive subtype of triple negative breast cancer into a clinical trial in under four years. Learn more

Protein Protecting T-cells Aids in Destruction of Liver Immune Cells
Liver Feature Image

A Houston Methodist research team led by Xian Li, MD, PhD, identified the surface protein OX40 as a mediator liver immune cell death, which initiates a cascade that results in liver inflammation and disease. Learn more.